When regulators do too little
Two decades after the FDA approved mass-market opioids, morgues are running out of room
This is the editor's letter in the current issue of The Week magazine.
In Ohio, coroner's offices are running out of room to store bodies, so they've brought in refrigerated trucks. Deaths from overdoses of opioids, heroin, and synthetic painkillers have soared about 50 percent in just a year. The casualties are piling up in every state: Overdoses killed about 60,000 Americans in 2016, The New York Times reported this week. It's hard to put the scope of this ongoing, man-made disaster in proper perspective: Drugs are killing nearly twice as many Americans as gun violence. Terrorism? Not even close. We're losing people to overdoses at a rate equivalent to 20 9/11 massacres every year. In a lawsuit filed last week against five pharmaceutical companies, Ohio joined more than a dozen other states and cities that have charged that drugmakers deliberately used a deceptive marketing campaign to turn powerful opioids into a mass consumer product. Purdue Pharma, it's been shown, told doctors the risk of addiction to OxyContin was "less than 1 percent."
When companies and industries lobby against regulations, they invariably call them "job killing." Undoubtedly, some regulations are needlessly cumbersome and costly. But the failure to regulate can also be a killer — of people, not jobs. In the 1990s, the Food and Drug Administration didn't challenge the claims of drugmakers that opioids were safe and rarely addictive — a decision that effectively legalized heroin-in-a-pill. Today, two million Americans are addicted to prescription opioids, and at least one million more are shooting up cheaper, easier-to-buy heroin and fentanyl. Our kids, parents, and neighbors are dying in droves; courts, police, drug-treatment agencies, and morgues are overwhelmed; entire communities have been hollowed out, as if by a plague. Two decades into a legally created epidemic, lawsuits and the FDA have finally reined in the sale of prescription painkillers. But for hundreds of thousands of people and those who loved them, the reckoning has come too late.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
William Falk is editor-in-chief of The Week, and has held that role since the magazine's first issue in 2001. He has previously been a reporter, columnist, and editor at the Gannett Westchester Newspapers and at Newsday, where he was part of two reporting teams that won Pulitzer Prizes.
-
The Week contest: Swift stimulus
Puzzles and Quizzes
By The Week US Published
-
'It's hard to resist a sweet deal on a good car'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
10 concert tours to see this winter
The Week Recommends Keep warm traveling the United States — and the world — to see these concerts
By Justin Klawans, The Week US Published